EarningsQ2 2026 Earnings Report
DE:IPF Q2 2026 EPS Results
Actual EPS€0.11
Consensus EPS€0.33
Beat/MissMissed by -€0.22
One Year Ago EPS€0.14
DE:IPF Q2 2026 Revenue Results
Actual Revenue€248.13M
Expected Revenue€249.37M
Beat/MissMissed by -€1.24M
YoY Revenue Growth+11.11%
Earnings Announcement Details
QuarterQ2 2026
Date08/04/2026
TimeBefore Open
Conference CallTuesday, August 4, 2026
DE:IPF Upcoming Earnings
IPG Photonics's next earnings date is estimated for November 3, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:IPF Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Positive
The call was strongly positive overall. The company reported a third consecutive quarter of double-digit revenue growth, stronger bookings with book-to-bill above one, improved adjusted profitability, and progress in industrial, semiconductor, medical, additive manufacturing, and defense initiatives. Key challenges included year-over-year declines in advanced solutions and North America, manufacturing absorption below target, tariff impacts, and continued pressure in parts of Europe, but these were outweighed by the company’s growth results, strategic wins, balance-sheet strength, and constructive outlook.Company Guidance
Third Consecutive Quarter of Double-Digit Revenue Growth
Second-quarter revenue was $279 million, up 11% year-over-year and growing sequentially, marking the company’s third consecutive quarter of double-digit year-over-year sales growth. Revenue was above the midpoint of guidance.
Bookings and Book-to-Bill Remained Strong
Bookings improved during the quarter, and book-to-bill remained above one for the third consecutive quarter, indicating sustained demand across the company’s end markets.
Industrial Solutions Growth Led by Welding and Battery Manufacturing
Industrial solutions revenue increased 16% year-over-year and 4% sequentially, driven by growth in welding, marking, cleaning, and additive manufacturing. Welding growth benefited from increased demand and business wins in battery manufacturing across electric vehicles and stationary storage.
Emerging Growth Products Increased Mix
Emerging growth products accounted for 58% of total second-quarter revenue, up from 53% in the prior quarter. Strong growth in lasers and solutions for battery manufacturing processes drove the increase.
Subsystem Wins with Major Automotive Manufacturers
Subsystems revenue increased significantly year-over-year. The combination of Adjustable Mode Beam lasers, advanced beam delivery, real-time process monitoring, computer vision, and artificial intelligence supported recent wins with two major global automotive manufacturers.
Additive Manufacturing Growth and Productivity Gains
Additive manufacturing revenue grew significantly year-over-year. The company’s latest-generation lasers with proprietary beam-shaping capabilities increase process speeds by approximately 1.5 to 2 times, which management said translates into higher productivity and lower total cost per part for customers.
Advanced Solutions Improved Sequentially
Advanced solutions revenue increased 10% sequentially, driven by strong growth in semiconductor applications and sequential improvement in micromachining applications.
Semiconductor Business Gaining Traction
The company continued winning business with large semiconductor equipment manufacturers in lithography, metrology, and inspection. Management attributed the opportunity to differentiated laser and photonic solutions and accelerating AI-related demand for GPUs and high-bandwidth memory chips.
Lumibird Medical Acquisition Expands Higher-Margin Medical Platform
On July 16, the company entered into a binding offer to acquire Lumibird Medical, a global leader in ophthalmology diagnostic and treatment systems. Management expects the transaction to expand advanced solutions revenue into higher-margin medical markets, be accretive to gross margin, EBITDA, and adjusted EPS in the first year, and increase the addressable medical market by approximately $1 billion. Closing is expected in the fourth quarter of 2026.
Strong Medical Backlog and Long-Term Growth Outlook
Medical bookings and backlog remained strong, with shipments expected to increase in the second half of the year. Management expects new product approvals and introductions in 2026 and 2027 and expects the existing medical business to more than double over the next two to three years. Medical currently represents approximately 7% to 8% of revenue.
CROSSBOW Production Shipments and Testing Progress
The company began shipping Lockheed Martin’s CROSSBOW order in the second quarter and expects to ship more units in the third quarter. CROSSBOW was demonstrated at White Sands Missile Range, tested by multiple agencies in the United States and overseas, and validated in harsh conditions including monsoonal rain, extreme heat, sandstorms, and multi-week deployment scenarios.
Positive Regional Performance in Asia and Europe
Revenue in Asia increased 19% year-over-year and 8% sequentially, driven by strong welding demand tied to battery manufacturing. European revenue increased 5% year-over-year and 1% sequentially, driven by cleaning and additive manufacturing, partially offset by lower cutting revenue.
Improved Adjusted Profitability
Adjusted gross margin was 40.7%, above the top end of guidance. Adjusted operating income was $24 million, adjusted net income was $25 million, adjusted EPS was $0.58, and adjusted EBITDA was $49 million; adjusted EPS and adjusted EBITDA were both above the top end of guidance.
Cash Position and Debt-Free Balance Sheet
The company ended the quarter with $871 million in cash equivalents and short-term investments, $33 million in long-term investments, and no debt. Cash flow from operations was $38 million, improving significantly from the first quarter.
Cost Reduction and Margin Expansion Initiatives
Management is reducing product costs through higher-power optical components and fewer diodes, optimizing pricing where differentiation supports additional value, and pursuing manufacturing-efficiency improvements. The company is targeting further gross-margin improvements in the second half of 2026 and into 2027.
Strategic Investment and One-IPG Operating Model
The company is continuing to invest in growth opportunities, including its major fiber manufacturing facility in Germany, with full-year capital expenditures expected at $90 million to $100 million. The One-IPG operating model is intended to streamline operations, strengthen decision-making, and accelerate product development.
Third-Quarter Guidance Provided
For the third quarter of 2026, the company expects revenue of $265 million to $295 million, adjusted gross margin of 37.5% to 40.5%, adjusted operating expenses of $92 million to $95 million, adjusted EPS of $0.30 to $0.60, and adjusted EBITDA of $35 million to $51 million.
DE:IPF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed